Authors: Katharina Wolff-Kuhne, PhD; Malte Glüsen, MSc; Dr. Lydia Frick, MSc, PhD; Dr. Matthias P. Schönermark, PhD, MD. Kintiga, Hannover, […]
Authors: Marieke Schurer, MSc; Melanie van Riemsdijk, PharmD, PhD. Kintiga, Ghent, Belgium. Abstract OBJECTIVES In health technology assessments (HTA), inclusion of
Authors: Ben Barron-Millar, PhD; Malcolm Boyd, MSc. Kintiga, Cambridge, United Kingdom. Abstract OBJECTIVES Advances therapy medicinal products (ATMPs) present significant challenges
Authors: Praptee Ghimire, MSc; Ben Lanning, PhD; Tejas Pethkar, BSc; Anna Macbeth, BSc; Jessica Radford, BSc; Priscila Mazzola, PhD. Kintiga,
Strategic Implications for Pharma & Biotech from ASCO 2026 Author: Univ.-Prof. Dr. Matthias P. Schönermark, Chief Strategy Officer Every
Author: Albert Kwarciak Tuesday 11th Nov 2025 Poster Presentation: 10:30 – 13:30 Discussion Period: 12:30 – 13:30 OBJECTIVES A recent
Authors: Joey Rehkopf, Malte Glüsen, Sebastian Vinzens, Ingo Hantke, Matthias P. Schönermark Tuesday 11th Nov 2025 Poster Presentation: 10:30 –
Authors: Marlies Boeren, Maud Brijs, Kristof Theys, Ben Barron-Millar, Malcolm Boyd, Malte Glüsen, Ingo Hantke, Priscila Mazzola, Melanie van Riemsdijk
Authors: Jacob Sebastian Vinzens, Ingo Hantke, Claire Helen Blaney, Maud Brijs, Matthias P. Schönermark. Tuesday 11th Nov 2025 Poster Presentation:
Authors: Lara Schroeder, Florian Stieglitz, Matthias P. Schönermark Tuesday 11th Nov 2025 Poster Presentation: 10:30 – 13:30 Discussion Period: 12:30
